153 related articles for article (PubMed ID: 25005715)
1. Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia.
Sugimoto K; Nishi H; Miyazawa T; Wada N; Izu A; Enya T; Okada M; Takemura T
BMC Nephrol; 2014 Jul; 15():109. PubMed ID: 25005715
[TBL] [Abstract][Full Text] [Related]
2. IVIG-triggered tubulointerstitial nephritis in X-linked agammaglobulinemia.
Takeguchi M; Korematsu S; Miyahara H; Kuga S; Izumi T
Pediatr Int; 2017 Aug; 59(8):945-946. PubMed ID: 28707726
[No Abstract] [Full Text] [Related]
3. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous immunoglobulin replacement therapy in X-linked agammaglobulinemia].
Kanegane H; Nomura K; Futatani T; Miyawaki T
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):337-43. PubMed ID: 16583740
[TBL] [Abstract][Full Text] [Related]
5. Eczema and X-linked agammaglobulinaemia.
Hunter HL; McKenna KE; Edgar JD
Clin Exp Dermatol; 2008 Mar; 33(2):148-50. PubMed ID: 18076688
[TBL] [Abstract][Full Text] [Related]
6. Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy.
Sag AT; Saka E; Ozgur TT; Sanal O; Ayvaz DC; Elibol B; Kurne AT
Cogn Behav Neurol; 2014 Sep; 27(3):155-9. PubMed ID: 25237746
[TBL] [Abstract][Full Text] [Related]
7. [X-linked agammaglobulinemia: experience in a Portuguese hospital].
Fernandes A; Guedes M; Vasconcelos J; Neves E; Fernandes S; Marques L
An Pediatr (Barc); 2015 Mar; 82(3):166-71. PubMed ID: 25443324
[TBL] [Abstract][Full Text] [Related]
8. X-linked Agammaglobulinemia.
Suri D; Rawat A; Singh S
Indian J Pediatr; 2016 Apr; 83(4):331-7. PubMed ID: 26909497
[TBL] [Abstract][Full Text] [Related]
9. [X-linked agammaglobulinemia in adults. Clinical evolution].
Giorgetti OB; Paolini MV; Oleastro MM; Fernández Romero DS
Medicina (B Aires); 2016; 76(2):65-70. PubMed ID: 27135842
[TBL] [Abstract][Full Text] [Related]
10. Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin.
Endo LM; Giannobile JV; Dobbs AK; Foote JB; Szymanska E; Warnock DG; Cook WJ; Conley ME; Schroeder HW
J Investig Allergol Clin Immunol; 2011; 21(5):405-9. PubMed ID: 21905506
[TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia.
Yoshino A; Honda M; Kanegane H; Obata K; Matsukura H; Sakazume S; Katada Y; Miyawaki T; Ueda Y; Nagai T
Pediatr Nephrol; 2006 Jan; 21(1):36-8. PubMed ID: 16550363
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
[TBL] [Abstract][Full Text] [Related]
13. Membranoproliferative Glomerulonephritis Type I Associated with Intravenous Immunoglobulin Administration Arising in a Child with X-Linked Agammaglobulinemia: A Case Report and a Reappraisal.
Hussein MRA; Babiker M; Asim S; Elsamwal M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):660-665. PubMed ID: 38725215
[TBL] [Abstract][Full Text] [Related]
14. X-linked agammaglobulinemia - first case with Bruton tyrosine kinase mutation from Pakistan.
Zaidi SK; Qureshi S; Qamar FN
J Pak Med Assoc; 2017 Mar; 67(3):471-473. PubMed ID: 28304004
[TBL] [Abstract][Full Text] [Related]
15. Predominant tubulointerstitial lupus nephritis with preceding pernicious anemia.
Ohashi A; Yamanishi A; Kondo M; Ihara F; Kondo F; Tanaka T; Maeda Y
CEN Case Rep; 2021 Aug; 10(3):393-401. PubMed ID: 33548028
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory observation on immunoglobulin replacement therapy switching from an intravenous to a subcutaneous route in a Malaysian X-linked agammaglobulinemia patient.
Adli A; Wahab AA; Abdul Latiff AH; Ismail IH; Faizah MZ; Boekhren KB; Noh LM
Med J Malaysia; 2022 Jan; 77(1):95-97. PubMed ID: 35087003
[TBL] [Abstract][Full Text] [Related]
17. A child with X-linked agammaglobulinemia and Kawasaki disease: an unusual association.
Sharma D; Guleria S; Suri D; Rawat A; Garg R; Singh S
Rheumatol Int; 2017 Aug; 37(8):1401-1403. PubMed ID: 28365793
[TBL] [Abstract][Full Text] [Related]
18. Iris atrophy in a patient with X-linked agammaglobulinemia.
Reisli I; Artac H; van der Burg M; Ozturk BT
Can J Ophthalmol; 2007 Dec; 42(6):882-3. PubMed ID: 18059520
[No Abstract] [Full Text] [Related]
19. An IgA1-lambda-type monoclonal immunoglobulin deposition disease associated with membranous features in a patient with IgG4-related kidney disease: a case report.
Kitazawa A; Koda R; Yoshino A; Ueda Y; Takeda T
BMC Nephrol; 2018 Nov; 19(1):330. PubMed ID: 30458736
[TBL] [Abstract][Full Text] [Related]
20. Acute tubulointerstitial nephritis following intravenous immunoglobulin therapy in a male infant with minimal-change nephrotic syndrome.
Tanaka H; Waga S; Tateyama T; Sugimoto K; Kakizaki Y; Yokoyama M
Tohoku J Exp Med; 1999 Oct; 189(2):155-61. PubMed ID: 10775058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
